US Stock MarketDetailed Quotes

BCLI Brainstorm Cell Therapeutics

Watchlist
  • 0.567
  • +0.047+9.02%
Close May 20 16:00 ET
39.74MMarket Cap-1829P/E (TTM)

Brainstorm Cell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Brainstorm Cell Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.05

+64.29%
Analyst Rating

No Data

Brainstorm Cell Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
Nov 14, 20232023/Q30.000 / 0.000--
Aug 14, 20232023/Q20.000 / 0.000--
May 15, 20232023/Q10.000 / 0.000--
Mar 30, 20232022/Q40.000 / 0.000--
Nov 14, 20222022/Q30.000 / 0.000--
Aug 15, 20222022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
Nov 14, 20232023/Q30.000 / 0.000--
Aug 14, 20232023/Q20.000 / 0.000--
May 15, 20232023/Q10.000 / 0.000--
Mar 30, 20232022/Q40.000 / 0.000--
Nov 14, 20222022/Q30.000 / 0.000--
Aug 15, 20222022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Brainstorm Cell Therapeutics Earnings Reports

  • Brainstorm Cell Therapeutics | 10-Q: Quarterly report

    May 14 16:07

  • Brainstorm Cell Therapeutics | 10-K: Annual report

    Apr 1 08:21

  • Brainstorm Cell Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 06:45

  • Brainstorm Cell Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 06:31

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg